CALGENT BIOTECHNOLOGY CO is a company that provides Ubiquitin ligase, Cancer, Cancer cell and more. CALGENT BIOTECHNOLOGY CO is headquartered in China Taiwan Province. CALGENT BIOTECHNOLOGY CO was founded in 2019. CALGENT BIOTECHNOLOGY CO has a total of 8 patents
Led by Dr. Yun Yen, the team aims for a first-in-class, low toxicity oral anti-cancer drug namely MPT0L056, an ITCH E3 ubiquitin ligase inhibitor which...